PS12 - 6. Selective cognitive decline is related to focal brain volume loss in type 1 diabetes patients with microangiopathy: a 4 year follow-up

Durable Reduction in MRI Disease Activity and Slowing of Brain Volume Loss With Alemtuzumab in Patients With Active RRMS: 7-Year Follow-up of CARE-MS I Patients (TOPAZ Study)

10.26226/morressier.59a3edacd462b8028d895458 ◽

2017 ◽

Author(s):

Douglas L. Arnold

Keyword(s):

Disease Activity ◽

Brain Volume ◽

Volume Loss ◽

Relapsing Remitting Multiple Sclerosis

Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in Relapsing-remitting Multiple Sclerosis Patients Over 8 Years: Care-MS Ii Follow-up (topaz Study)

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2018.10.086 ◽

2018 ◽

Vol 26 ◽

pp. 258 ◽

Cited By ~ 1

Author(s):

R. Alroughani ◽

B.A. Singer ◽

S. Broadley ◽

S. Eichau ◽

H. Hartung ◽

...

Keyword(s):

Multiple Sclerosis ◽

Disease Activity ◽

Brain Volume ◽

Volume Loss ◽

Brain Volume Loss ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

SMARTDIAB: A Communication and Information Technology Approach for the Intelligent Monitoring, Management and Follow-up of Type 1 Diabetes Patients

IEEE Transactions on Information Technology in Biomedicine ◽

10.1109/titb.2009.2039711 ◽

2010 ◽

Vol 14 (3) ◽

pp. 622-633 ◽

Cited By ~ 64

Author(s):

Stavroula G. Mougiakakou ◽

Christos S. Bartsocas ◽

Evangelos Bozas ◽

Nikos Chaniotakis ◽

Dimitra Iliopoulou ◽

...

Keyword(s):

Information Technology ◽

Type 1 Diabetes ◽

Intelligent Monitoring ◽

Communication And Information Technology ◽

Ten years follow up of first degree relatives of type 1 diabetes patients: presence of autoimmune biomarkers and the progression to diabetes in a retrospective cohort

Archives of Endocrinology and Metabolism ◽

10.20945/2359-3997000000370 ◽

2021 ◽

Author(s):

Isabella Sued Leão ◽

Débora Batista Araujo ◽

Bianca Barone ◽

Joana Rodrigues Dantas ◽

Matheus Victor de Souza Nolasco da Silva ◽

...

Keyword(s):

Type 1 Diabetes ◽

Retrospective Cohort ◽

First Degree Relatives ◽

Alemtuzumab Reduced MRI Lesions and Slowed Brain Volume Loss in CARE-MS II Patients Switching From SC IFNB-1a: 5-Year Follow-up After Alemtuzumab (TOPAZ Study)

10.26226/morressier.59a3eda8d462b8028d89551b ◽

2017 ◽

Author(s):

Daniel Pelletier

Keyword(s):

Brain Volume ◽

Volume Loss ◽

Neurofilament light chain in CSF and serum in relation to disease activity and brain volume loss during four years of follow-up in a cohort of patients with CIS and RRMS

10.26226/morressier.59a3eda7d462b8028d894fe2 ◽

2017 ◽

Author(s):

Irene Håkansson

Keyword(s):

Disease Activity ◽

Light Chain ◽

Brain Volume ◽

Volume Loss ◽

Neurofilament Light Chain ◽

Neurofilament Light ◽

Brain volume loss precedes cognitive decline in the first year after ischaemic stroke

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp-2017-316074.6 ◽

2017 ◽

Vol 88 (5) ◽

pp. e1.59-e1

Author(s):

Emilio Werden ◽

Toby Cumming ◽

Laura Bird ◽

Mohamed Khlif ◽

Amy Brodtmann

Keyword(s):

Cognitive Decline ◽

Ischaemic Stroke ◽

Brain Volume ◽

First Year ◽

Volume Loss ◽

Metabolic control in type 1 diabetes patients practicing combat sports: at least two-year follow-up study

SpringerPlus ◽

10.1186/s40064-015-0919-5 ◽

2015 ◽

Vol 4 (1) ◽

Cited By ~ 5

Author(s):

Teresa Benbenek-Klupa ◽

Bartlomiej Matejko ◽

Tomasz Klupa

Keyword(s):

Type 1 Diabetes ◽

Metabolic Control ◽

Combat Sports ◽

Follow Up Study ◽

Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B

Archives of Neurology ◽

10.1001/archneurol.2009.272 ◽

2009 ◽

Vol 66 (12) ◽

Cited By ~ 187

Author(s):

Martha Storandt ◽

Mark A. Mintun ◽

Denise Head ◽

John C. Morris

Keyword(s):

Cognitive Decline ◽

Brain Volume ◽

Amyloid Β ◽

Amyloid Β Peptide ◽

Volume Loss ◽

Pittsburgh Compound B ◽

Brain Volume Loss ◽

Cerebral Amyloid

Alemtuzumab Decreased MRI Disease Activity and Slowed Brain Volume Loss Over 5 Years After Switching From SC IFNB-1a: Follow-up of CARE-MS I (TOPAZ Study)

10.26226/morressier.59a3eda8d462b8028d895557 ◽

2017 ◽

Cited By ~ 1

Author(s):

Alex Rovira

Keyword(s):

Disease Activity ◽

Brain Volume ◽

Volume Loss ◽